[A case of malignant insulin-producing pancreatic tumor treatment].
Reutova
E V
EV
Orel
N F
NF
Besova
N S
NS
Artemova
E V
EV
Smirnova
N B
NB
Gorbunova
V A
VA
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007340:Insulinoma / Q000188:drug therapy / Q000378:metabolism* / Q000556:secondary; D008113:Liver Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000556:secondary; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D015282:Octreotide / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology
C113217:3-arabinopyranosyl-1-methyl-1-nitrosourea; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D007328:Insulin; D009607:Nitrosourea Compounds; D015282:Octreotide